Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Nastech claims formulations of sildenafil for nasal delivery

Feb. 11, 2000

Inhibitors of cGMP-PDEs under study at Bayer

Feb. 9, 2000

RenaGel receives marketing approval in the E.U.

Feb. 4, 2000

Edex/Viridal preferred, more efficacious than other ED therapies

Feb. 2, 2000

Patients prefer Invicorp over Caverject

Feb. 1, 2000

New Zeria compounds with alpha1-adrenoceptor-blocking effects

Feb. 1, 2000

OPC-41061 + furosemide: additive diuretic effect + beneficial effect on electrolytes

Jan. 31, 2000

Bayer presents new candidate treatment for ED at ESIR

Jan. 31, 2000

IC-351 improves erectile response to visual stimulation in men with mild to moderate ED

Jan. 31, 2000

New formulation of Xatral receives European approvals

Jan. 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...